Nisin

Nisin is a 34-amino acid lantibiotic (lanthionine-containing antibiotic) produced by certain strains of Lactococcus lactis, a bacterium commonly used in dairy fermentation. Discovered in 1928, nisin has been used as a food preservative since the 1950s and is one of the few antimicrobial peptides with a long track record of commercial use. It is designated as E234 in the European food additive numbering system and has been approved for food use in over 80 countries.

Nisin's antimicrobial mechanism involves a dual mode of action against Gram-positive bacteria. First, it binds to lipid II, an essential precursor molecule in bacterial cell wall synthesis, thereby inhibiting peptidoglycan production. Second, nisin uses lipid II as a docking molecule to form pores in the bacterial membrane, leading to rapid cell death through loss of ions, amino acids, and ATP. This dual mechanism makes it highly effective and reduces the likelihood of resistance development.

The peptide is particularly effective against Gram-positive bacteria, including clinically important pathogens such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), and Clostridium difficile. It also inhibits the outgrowth of bacterial spores, which is particularly valuable in food safety applications for controlling Clostridium botulinum and Listeria monocytogenes.

Research into therapeutic applications of nisin extends beyond food preservation. Studies have explored its potential in treating bacterial infections, particularly those caused by antibiotic-resistant organisms. Nisin has been investigated for wound care, dental health (it is effective against oral pathogens), and even as an adjunct to conventional antibiotics. Its long history of safe use in food provides a strong safety foundation for these therapeutic explorations.